Archive for April 2020
COVID-19 Response
BTS Research is taking in animals for temporary housing from local vivariums BTS provides services in the following research animals: Rodents. Rabbits. Guinea pigs. Dogs NHP’s. Contact us for more details.
Read MoreMHRA Temporarily Eases Some GMP Requirements
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) is relaxing some GMP requirements to help manufacturers overcome challenges during the COVID-19 pandemic. Source: Devices & Diagnostics Letter
Read MoreRemdesivir Trial Data Leak Shows No Benefits in COVID-19 Patients
Results from a Chinese trial of Gilead’s antiviral remdesivir show no benefit in COVID-19 patients, according to data accidentally posted on the World Health Organization’s (WHO) website. Source: Devices & Diagnostics Letter
Read MoreFDA Eases Requirements for Repackaging of Propofol
In an emergency final guidance released yesterday, the FDA agency said it is temporarily relaxing its regulations for repackaging and combining units of propofol during the COVID-19 pandemic. Source: Devices & Diagnostics Letter
Read MoreJ&J Partners With Emergent to Produce COVID-19 Vaccine
Johnson & Johnson is partnering with Emergent Biosolutions to scale up manufacturing of a COVID-19 vaccine. Source: Devices & Diagnostics Letter
Read MoreNew York Files Opioid Fraud Charges Against Mallinckrodt
The state of New York has filed civil charges against Mallinckrodt for its alleged role in the opioid epidemic. Source: Drug Industry Daily
Read MoreInsmed’s Brensocatib Enters Trial as Possible COVID-19 Treatment
Insmed is sponsoring a clinical trial in the UK of its bronchial drug Brensocatib as a potential COVID-19 treatment. Source: Drug Industry Daily
Read MoreValneva and Dynavax Collaborate to Develop COVID-19 Vaccine
Dynavax used the adjuvant in its FDA-approved hepatitis B vaccine. Source: Devices & Diagnostics Letter
Read MoreFDA Approves Sanofi’s Meningococcal Vaccine
MenQuadfi will be available in a ready-to-use liquid formulation to allow healthcare providers to avoid vaccine reconstitution. Source: Devices & Diagnostics Letter
Read MoreFDA Approves Immunomedic’s Breast Cancer Treatment Trodelvy
The FDA previously granted the drug priority review, breakthrough therapy and fast- track designations. Source: Devices & Diagnostics Letter
Read More